Q5XFR0
Gene name |
Pabpn1l (Epabp2, Gm1108, Pabpnl1) |
Protein name |
Embryonic polyadenylate-binding protein 2 |
Names |
Embryonic poly(A)-binding protein 2, ePABP-2, ePABP2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:382035 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5XFR0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5XFR0-F1 | Predicted | AlphaFoldDB |
29 variants for Q5XFR0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389014710 | 9 | L>V | No | EVA | |
| rs236908482 | 34 | G>S | No | EVA | |
| rs264790772 | 37 | E>K | No | EVA | |
| rs248907333 | 45 | A>V | No | EVA | |
| rs3388967158 | 54 | E>K | No | EVA | |
| rs259824009 | 79 | F>Y | No | EVA | |
| rs3399717448 | 83 | L>F | No | EVA | |
| rs3389014742 | 94 | E>Q | No | EVA | |
| rs3389022826 | 98 | A>V | No | EVA | |
| rs1133448735 | 102 | P>T | No | EVA | |
| rs3388986293 | 103 | P>S | No | EVA | |
| rs1134807238 | 105 | V>I | No | EVA | |
| rs1134224468 | 108 | K>R | No | EVA | |
| rs33110169 | 113 | E>K | No | EVA | |
| rs3413072071 | 119 | Q>R | No | EVA | |
| rs3389020557 | 177 | D>G | No | EVA | |
| rs3389010841 | 180 | S>Y | No | EVA | |
| rs3389022789 | 194 | H>Q | No | EVA | |
| rs3389016116 | 195 | R>T | No | EVA | |
| rs3389016687 | 208 | F>I | No | EVA | |
| rs3389014743 | 211 | R>W | No | EVA | |
| rs3388992336 | 213 | I>F | No | EVA | |
| rs3388992336 | 213 | I>V | No | EVA | |
| rs3389016110 | 225 | I>N | No | EVA | |
| rs3389016693 | 226 | S>I | No | EVA | |
| rs33250225 | 239 | N>S | No | EVA | |
| rs3389010859 | 245 | H>Y | No | EVA | |
| rs254301586 | 264 | G>R | No | EVA | |
| rs3388998078 | 266 | A>S | No | EVA |
No associated diseases with Q5XFR0
1 regional properties for Q5XFR0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | RNA recognition motif domain | 143 - 220 | IPR000504 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| poly(A) binding | Binding to a sequence of adenylyl residues in an RNA molecule, such as the poly(A) tail, a sequence of adenylyl residues at the 3' end of eukaryotic mRNA. |
| RNA binding | Binding to an RNA molecule or a portion thereof. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| maternal-to-zygotic transition of gene expression | Any process that modulates the frequency, rate or extent of gene expression by which developmental control passes from the maternal genome to the zygotic genome. |
| negative regulation of protein binding | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| negative regulation of protein ubiquitination | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process | Any process that stops or decreases the rate, frequency or extent of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome. |
| nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | A major pathway of degradation of nuclear-transcribed mRNAs that proceeds through a series of ordered steps that includes poly(A) tail shortening and that can regulate mRNA stability. |
4 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q28165 | PABPN1 | Polyadenylate-binding protein 2 | Bos taurus (Bovine) | PR |
| Q86U42 | PABPN1 | Polyadenylate-binding protein 2 | Homo sapiens (Human) | PR |
| Q8CCS6 | Pabpn1 | Polyadenylate-binding protein 2 | Mus musculus (Mouse) | PR |
| B0BNE4 | Pabpn1l | Embryonic polyadenylate-binding protein 2 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEPYLSNELF | PPPTEAWLQT | VSSDPEAQGW | GAWGRTEKTS | LVPRAGSRAG | SDKEAEENED |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ASFLLSLLEP | ENLAKSPVFN | QELEAIKLKL | WAMEHAEAQP | EPPCVQRKAT | EEERAEVRQL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LSPETVDCFF | SRTSKENVEA | DHRSVFVGNV | DYGGSAAELE | AYFSPCGEIH | RVTILCDKFS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GHPKGYAYIE | FASHRSVKAA | VGLDESTFRG | RVIKVLPKRT | NFPGISSTDR | GGLRTHSGNR |
| 250 | 260 | 270 | |||
| AAFLHGSLHR | KARLRAHGRS | RGHGGAPQWF | SPY |